Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2002-08-02
2010-10-05
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S130100, C424S164100, C424S168100, C424S184100, C424S185100, C424S234100, C435S007100, C435S007200, C530S300000, C530S350000
Reexamination Certificate
active
07807182
ABSTRACT:
A number of protein and glycoprotein antigens secreted byMycobacterium tuberculosis(Mtb) have been identified as “early” Mtb antigens on the basis early antibodies present in subjects infected with Mtb prior to the development of detectable clinical disease. Epitope-bearing peptide fragments of these early Mtb antigens, in particular of an 88 kDa secreted protein, GlcB (SEQ ID NO:106) and of Mtb antigen MPT51 (SEQ ID NO:107) have been identified. These peptides, variants thereof, peptide multimers thereof that include two or more repeats of one or more of the peptides, and fusion polypeptides that include early Mtb antigenic proteins, peptides or both, are useful in immunoassay methods for early, rapid detection of TB in a subject. Preferred immunoassays detect the antibodies in the subject's urine. Also provided are antigenic compositions, kits and methods to useful for detecting an early Mtb antibodies. The antigenic proteins and peptides are also used in vaccine compositions.
REFERENCES:
patent: 5254459 (1993-10-01), Patarroyo
patent: 5330754 (1994-07-01), Kapoor et al.
patent: WO90/04041 (1990-04-01), None
patent: WO92/08809 (1992-05-01), None
patent: WO97/34149 (1997-09-01), None
E. O. E. Bassey et al., “Candidate Antigens for Improved Serodiagnosis of Tuberculosis,” Tubercle and Lung Disease, 1996, pp. 136-145, vol. 77.
Belisle John T.
Laal Suman
Zolla-Pazner Susan
Browdy and Neimark PLLC
Colorado State University Research Foundation
New York University
Swartz Rodney P.
LandOfFree
Early detection of mycobacterial disease using peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Early detection of mycobacterial disease using peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Early detection of mycobacterial disease using peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4199606